Rxsight

RXST · NASDAQ

$4.88+$0.19 (+4.05%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $4.69

Latest news

Press releaseAug 5, 4:05 PM ETGlobe Newswire
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
Press releaseJul 10, 1:55 PM ETBusiness Wire
Glancy Prongay Wolke & Rotter LLP Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
Press releaseJul 8, 12:00 PM ETBusiness Wire
Law Offices of Howard G. Smith Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
Press releaseJul 7, 3:05 PM ETBusiness Wire
The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
NewsJul 7, 8:33 AM ETRishabh Mishra
Stock Market Today: Dow Jones Futures Gain, S&P 500, Nasdaq 100 Slips As SpaceX Debuts On The Exchange—Rivian, Micron In Focus (UPDATED)
NewsJul 7, 3:23 AM ETAvi Kapoor
Rivian Automotive, Penguin Solutions And 3 Stocks To Watch Heading Into Tuesday
Press releaseJul 6, 4:15 PM ETBusiness Wire
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
Press releaseJul 6, 4:15 PM ETGlobe Newswire
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
Press releaseJul 6, 4:15 PM ETGlobe Newswire
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
Press releaseJul 2, 3:02 PM ETPRNewswire
Did RxSight, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
Press releaseMay 6, 4:05 PM ETGlobe Newswire
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
NewsFeb 26, 4:01 PM ET
What 5 Analyst Ratings Have To Say About RxSight
NewsFeb 25, 4:14 PM ET
RxSight Q4 Adj. EPS $(0.03) Beats $(0.33) Estimate, Sales $32.607M Beat $30.117M Estimate
Press releaseFeb 25, 4:05 PM ETGlobe Newswire
RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance
NewsFeb 25, 6:11 AM ET
Earnings Scheduled For February 25, 2026
Press releaseJan 22, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
NewsJan 20, 3:00 PM ET
Expert Outlook: RxSight Through The Eyes Of 5 Analysts
Press releaseJan 15, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
Press releaseJan 13, 4:23 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
NewsJan 12, 12:26 PM ETAvi Kapoor
Gold Rises Sharply; Lyra Therapeutics Shares Plunge
NewsJan 12, 10:07 AM ETAvi Kapoor
Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday
Press releaseJan 8, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
Press releaseJan 1, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
Press releaseDec 30, 12:32 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
NewsNov 21, 11:14 AM ETAvi Kapoor
Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday
NewsNov 6, 7:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseOct 8, 7:10 PM ETGlobe Newswire
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. is Investigating RxSight, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseSep 23, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
Press releaseSep 22, 2:18 PM ETBusiness Wire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Press releaseSep 22, 10:03 AM ETGlobe Newswire
RXSIGHT FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Urges RXST To Contact the Firm Regarding Class Action Lawsuit
Press releaseSep 22, 8:45 AM ETPRNewswire
Class Action Filed Against RxSight, Inc. (RXST) - September 22, 2025 Deadline to Join - Contact The Gross Law Firm
Press releaseSep 22, 4:24 AM ETPRNewswire
RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST
Press releaseSep 22, 3:38 AM ETPRNewswire
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Press releaseSep 21, 7:22 AM ETGlobe Newswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Press releaseSep 20, 9:16 AM ETPRNewswire
RXST Deadline: RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit
Press releaseSep 20, 7:36 AM ETGlobe Newswire
INVESTOR CLASS ACTION: RxSight, Inc. Investors are Reminded of the Ongoing Securities Fraud Lawsuit after Stock Plummeted 38% -- Contact BFA Law
Press releaseSep 19, 1:46 PM ETBusiness Wire
Deadline Soon: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Press releaseSep 19, 8:45 AM ETPRNewswire
RxSight, Inc. Class Action: Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - RXST
Press releaseSep 18, 7:20 PM ETPRNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Press releaseAug 5, 7:39 PM ETGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm
Press releaseAug 2, 1:56 PM ETGlobe Newswire
Bragar Eagel & Squire, P.C. Is Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm
Press releaseJul 28, 8:03 PM ETGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm
Press releaseJul 27, 9:58 AM ETGlobe Newswire
Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Luminar Technologies, Inc. (NASDAQ: LAZR); Replimune Group, Inc. (NASDAQ: REPL); and RxSight, Inc. (NASDAQ: RXST): Grabar Law Office is Investigating Claims on Your Behalf
Press releaseJul 25, 12:11 PM ETGlobe Newswire
DEADLINE ALERT for BHVN, NEOG, and RXST: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook

Glancy Prongay Wolke & Rotter LLP Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

Law Offices of Howard G. Smith Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors

Stock Market Today: Dow Jones Futures Gain, S&P 500, Nasdaq 100 Slips As SpaceX Debuts On The Exchange—Rivian, Micron In Focus (UPDATED)

Rivian Automotive, Penguin Solutions And 3 Stocks To Watch Heading Into Tuesday

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Did RxSight, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Earnings Scheduled For May 6, 2026

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

What 5 Analyst Ratings Have To Say About RxSight

RxSight Q4 Adj. EPS $(0.03) Beats $(0.33) Estimate, Sales $32.607M Beat $30.117M Estimate

RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance

Earnings Scheduled For February 25, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

Expert Outlook: RxSight Through The Eyes Of 5 Analysts

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

Gold Rises Sharply; Lyra Therapeutics Shares Plunge

Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday

12 Health Care Stocks Moving In Thursday's Pre-Market Session

RXSIGHT ALERT: Bragar Eagel & Squire, P.C. is Investigating RxSight, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

RXSIGHT FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Urges RXST To Contact the Firm Regarding Class Action Lawsuit

Class Action Filed Against RxSight, Inc. (RXST) - September 22, 2025 Deadline to Join - Contact The Gross Law Firm

RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST

RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

RXST Deadline: RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit

INVESTOR CLASS ACTION: RxSight, Inc. Investors are Reminded of the Ongoing Securities Fraud Lawsuit after Stock Plummeted 38% -- Contact BFA Law

Deadline Soon: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

RxSight, Inc. Class Action: Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - RXST

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Is Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm

Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Luminar Technologies, Inc. (NASDAQ: LAZR); Replimune Group, Inc. (NASDAQ: REPL); and RxSight, Inc. (NASDAQ: RXST): Grabar Law Office is Investigating Claims on Your Behalf

DEADLINE ALERT for BHVN, NEOG, and RXST: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders